Cash from Financing (Quarterly) Chart

View Cash from Financing (Quarterly) for ALGN.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Cash from Financing (Quarterly) Chart
Start Trial

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2000. Start Trial.
Date Value
June 30, 2026 -67.45M
March 31, 2026 -48.13M
December 31, 2025 -97.41M
September 30, 2025 -64.12M
June 30, 2025 -96.30M
March 31, 2025 -206.76M
December 31, 2024 -203.02M
September 30, 2024 10.57M
June 30, 2024 -151.56M
March 31, 2024 -11.72M
December 31, 2023 -350.28M
September 30, 2023 11.83M
June 30, 2023 -0.931M
March 31, 2023 -258.96M
December 31, 2022 -200.19M
September 30, 2022 10.90M
June 30, 2022 -200.65M
March 31, 2022 -111.74M
December 31, 2021 -101.57M
September 30, 2021 -65.00M
June 30, 2021 -238.32M
March 31, 2021 -53.44M
December 31, 2020 -2.448M
September 30, 2020 8.016M
June 30, 2020 -1.643M
Date Value
March 31, 2020 -34.73M
December 31, 2019 -102.38M
September 30, 2019 -194.78M
June 30, 2019 -95.62M
March 31, 2019 -92.76M
December 31, 2018 -54.28M
September 30, 2018 -144.41M
June 30, 2018 -30.92M
March 31, 2018 -139.82M
December 31, 2017 -56.46M
September 30, 2017 5.204M
June 30, 2017 -51.24M
March 31, 2017 -33.00M
December 31, 2016 -37.90M
September 30, 2016 -2.111M
June 30, 2016 -46.40M
March 31, 2016 -9.106M
December 31, 2015 -11.83M
September 30, 2015 -14.03M
June 30, 2015 -67.83M
March 31, 2015 -7.097M
December 31, 2014 -19.50M
September 30, 2014 -1.051M
June 30, 2014 -66.93M
March 31, 2014 21.06M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks
Start Trial
Dentsply Sirona, Inc. -11.00M
Integra LifeSciences Holdings Corp. -0.818M
Envista Holdings Corp. -60.70M
Intuitive Surgical, Inc. -287.90M
Boston Scientific Corp. -410.00M